These data are in agreement with lower activity of IFN-α in vivo during HIV-2 as compared to HIV-1 infection, that possibly explain the reduced refractoriness to IFN-α production upon further in vitro pDC stimulation observed in HIV-2 infected patients. The gene discussed is IFNA1; the disease is HIV-1 infection.